南方医科大学学报
南方醫科大學學報
남방의과대학학보
JOURNAL OF SOUTHERN MEDICAL UNIVERSITY
2009年
8期
1612-1614
,共3页
李旭桂%王广发%张俊艳%吴少瑜%徐伟%吴曙光%张嘉杰
李旭桂%王廣髮%張俊豔%吳少瑜%徐偉%吳曙光%張嘉傑
리욱계%왕엄발%장준염%오소유%서위%오서광%장가걸
蛋白酪氨酸激酶%时间分辨荧光免疫分析%血管内皮生长因子受体2
蛋白酪氨痠激酶%時間分辨熒光免疫分析%血管內皮生長因子受體2
단백락안산격매%시간분변형광면역분석%혈관내피생장인자수체2
protein-tyrosine kinases%vascular endothelia growth factor receptor 2%time-resolved immunofluorometric assay
目的 建立一种均相时间分辨荧光免疫分析方法用于蛋白酪氨酸激酶抑制剂的体外高通量筛选.方法 根据铕联穴状化合物(EuK)和异藻蓝蛋白(XL-665)两个荧光化合物在激发后的能量共振转移所发出的特异性荧光,采用多功能酶标仪在波长为612 nm和670 nm处测定荧光信号的变化;以血管内皮生长因子2(VEGFR-2)为蛋白酪氨酸激酶,检测蛋白酪氨酸激酶抑制剂Sunitinib的抑制活性.结果 建立了一种用于蛋白酪氨酸激酶抑制剂体外高通量筛选的均相时间分辨荧光免疫分析方法.在反应体系中,蛋白酪氨酸激酶VEGFR-2、三磷酸腺苷(ATP)和多肽底物浓度分别为5ng/μ1、100 μmol/L和1 μmol/L.在上述条件下,检测到Sunitinib 对 VEGFR-2酪氨酸激酶抑制活性的IC_(50)为86.7nmol/L,与文献报道的结果近似.结论 本实验所建立的均相时间分辨荧光免疫分析方法操作简便,重复性好,可用于蛋白酪氨酸激酶抑制剂的体外高通量筛选.
目的 建立一種均相時間分辨熒光免疫分析方法用于蛋白酪氨痠激酶抑製劑的體外高通量篩選.方法 根據銪聯穴狀化閤物(EuK)和異藻藍蛋白(XL-665)兩箇熒光化閤物在激髮後的能量共振轉移所髮齣的特異性熒光,採用多功能酶標儀在波長為612 nm和670 nm處測定熒光信號的變化;以血管內皮生長因子2(VEGFR-2)為蛋白酪氨痠激酶,檢測蛋白酪氨痠激酶抑製劑Sunitinib的抑製活性.結果 建立瞭一種用于蛋白酪氨痠激酶抑製劑體外高通量篩選的均相時間分辨熒光免疫分析方法.在反應體繫中,蛋白酪氨痠激酶VEGFR-2、三燐痠腺苷(ATP)和多肽底物濃度分彆為5ng/μ1、100 μmol/L和1 μmol/L.在上述條件下,檢測到Sunitinib 對 VEGFR-2酪氨痠激酶抑製活性的IC_(50)為86.7nmol/L,與文獻報道的結果近似.結論 本實驗所建立的均相時間分辨熒光免疫分析方法操作簡便,重複性好,可用于蛋白酪氨痠激酶抑製劑的體外高通量篩選.
목적 건립일충균상시간분변형광면역분석방법용우단백락안산격매억제제적체외고통량사선.방법 근거유련혈상화합물(EuK)화이조람단백(XL-665)량개형광화합물재격발후적능량공진전이소발출적특이성형광,채용다공능매표의재파장위612 nm화670 nm처측정형광신호적변화;이혈관내피생장인자2(VEGFR-2)위단백락안산격매,검측단백락안산격매억제제Sunitinib적억제활성.결과 건립료일충용우단백락안산격매억제제체외고통량사선적균상시간분변형광면역분석방법.재반응체계중,단백락안산격매VEGFR-2、삼린산선감(ATP)화다태저물농도분별위5ng/μ1、100 μmol/L화1 μmol/L.재상술조건하,검측도Sunitinib 대 VEGFR-2락안산격매억제활성적IC_(50)위86.7nmol/L,여문헌보도적결과근사.결론 본실험소건립적균상시간분변형광면역분석방법조작간편,중복성호,가용우단백락안산격매억제제적체외고통량사선.
Objective To establish an in vitro homogeneous time-resolved fluorescence immunoassay method for high throughput screening of protein tyrosine kinase (PTK) inhibitors. Methods Specific fluorescence signals at 670 and 612 nm were measured by multifunctional microplate reader when the fluorescence was emitted through a resonance energy transfer between fluorescent materials (EuK and XL-665). The inhibitory activity of Sunitinib, a standard PTK inhibitor, on vascular endothelia growth factor receptor 2 (VEGFR-2) kinase activity was investigated. Results A homogeneous time-resolved fluorescence immunoassay was established for high throughput screening of PTK inhibitor. In this system, the concentrations of VEGFR-2, adenosine triphosphate (ATP) and poly-peptide substrate were 5 ng/μ1, 100 μmol/L and 1 μmol/L,respectively. Sunitinib inhibited VEGFR-2 kinase activity with an IC_(50) value of 86.7 nmol/L, which was close to the values tested using other methods. Conclusion The homogeneous time-resolved fluorescence immunoassay we established can be easily used for high throughput screening of PTK inhibitors.